| Pharmaceuticals Manufacturing | Produces Beta-Lactam and Non-Beta-Lactam tablets, capsules, oral liquids, and topical preparations. | Comprehensive drug approvals portfolio, strategic manufacturing location, and expanding R&D capabilities. | Primarily B2B with hospitals, clinics, pharmacies, and also indirect B2C through retail channels. | Specialized Beta-Lactam formulations and oral liquids where differentiation is stronger. | 15 | 100 | Revenue from sales of pharmaceutical products to healthcare providers, distributors, and pharmacies. | Direct sales with pricing aligned to market standards and regulatory frameworks. | Regulatory approvals, expanded manufacturing capacity, rising demand for Beta-Lactam antibiotics and general medicines. | |
